Thank you, Dan, and thank you to everyone on the call today. I hope that all of you and your family and friends are staying safe and healthy during what is a very stressful time for people in our country and the world over. Before we begin, let me say a few words about the coronavirus. This is an issue that we are all intensely focused on throughout our organization. The health and safety of our employees is our paramount concern. We've encouraged our team to telework to the maximum extent possible including for this phone call. We’re taking a series of other steps to protect those employees who are not able to telework, which includes a portion of our workforce at our secure in Tennessee and Ohio. From a business standpoint, we are fortunate that the vast majority of our revenue is tied to long-term contracts with large entities like electrical utilities in the U.S. government. We expect that we will continue to make our fuel deliveries to our utility customers here in the United States and around the world. We are also continuing our work under our three-year, $115 million contract with the U.S. Department of Energy to deploy a demonstration cascade of centrifuges in Ohio. However, we expect that there will be impacts on cost and schedule for that project. We are working closely with DOE and are continuing to make progress on the program. With that, let me turn to our financial results for 2019. I'm pleased to report that it was a very strong year for Centrus. The price reset provision in our largest supply contract took effect on January 1, 2019, which has significantly reduced our cost of sales in our LEU segment. Prices in the enrichment market fell by 75% between 2011 and late 2018, and since then have rebounded 35% from the low point. The price adjustment that kicked in at the beginning of 2019 better aligns our contract with market conditions. As a result, we had better margins in 2019 and we'll continue to benefit from the lower price structure in the years to come. At the end of the third quarter right on schedule, we fully repaid $27.5 million in notes that came due on September 30. That note repayment marked another milestone in our effort to reduce, restructure and retire our debt. We also successfully completed the decontamination and decommissioning of DOE's K-1600 facility at the East Tennessee Technology Park, demonstrating our D&D capabilities and extending our track record of delivering projects on time and on budget. In October, we finalized the three year, $115 million contract I mentioned earlier with the U.S. Department of Energy to demonstrate production of high-assay low-enriched uranium or HALEU as we call it, an advanced nuclear fuel that will be needed in the future to power both the existing fleet of reactors and a new generation of reactors around the world. We're deploying a cascade of our AC-100M machines at our facility in Piketon, Ohio to demonstrate the capability to produce a small quantity of HALEU. While the contract includes a significant cost share requirement, we view this demonstration as a strategic investment that will position Centrus to return to the commercial enrichment market and establish the Company as a global leader in the emerging markets for higher assay fuels. Thanks in part to the HALEU contract. We've seen significant growth potential in our technology -- Technical Solutions segment. Our overall performance in 2019 also saw improvement with lower cost of sale and reduced overhead. For the full year, Centrus is reporting a net loss of $16.5 billion in 2019, a significant improvement over 2018. In fact or not for the loss we accrued in the fourth quarter to reflect the investment we intend to make in the cost-shared HALEU contract over the next three years, we actually would have posted a small net profit in 2019. As you may recall, based on developments during the second quarter, we upgraded our 2019 revenue guidance to be in a range between $205 million and $230 million. I'm pleased to report that we met that target with total revenues of $209.7 million. This includes separate work units and uranium revenue of $169.4 million and a cash balance of $130.7 million at year end. We’ve also ended the year with an order book in our LEU segment valued at $1 billion as of December 31, 2019. Looking at 2020, we are in a strong position with our new lower-cost structure and the revenues we expect to generate from our adjusting contrasts in both business segments. However, one variable we cannot control is the global economy, which is now a source of considerable uncertainty. For example, the recent decline in the stock market coupled with the Fed's decision to lower interest rates will affect our pension assets and liabilities, which in turn gets reflected in our bottom line as actuarial changes to the non-operating components from net periodic benefit expense. Of course, this was only March, a lot can happen between now and December 31st. The economy could get better. It could get worse. These are factors beyond our ability to control or to predict. Given the period of global economic volatility that we have now entered, we're just not comfortable making a prediction one way or another with respect to overall profitability. In addition to uncertainty surrounding the coronavirus pandemic and the global economy, the U.S. Department of Commerce is seeking a significant extension of the Russian Suspension Agreement, potentially extending limits on imports of Russian nuclear fuel past the scheduled exploration of those limits at the end of this year. We are working with U.S. government, industry stakeholders and others to urge that any potential extension include sufficient quota to allow all existing U.S. contracts with the Russian suppliers of enriched uranium, including our own supply contract, to be fully implemented. Now for more details on the quarterly and 2019 full year financial results, I will turn the call over to Philip.